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FACT OF ASTHMA
Asthma is a chronic inflammatory disease of the airway asso-
ciated with airway hyperresponsiveness and episodes of airway 
narrowing. Facts of asthma in WHO website in 2010 said;
· 300 million people suffer from asthma. 
· 255,000 people died of asthma in 2005. 
· Prevalence of asthma is increased or increasing. 
· Asthma is the most common disease among children. 
·  Over 80% of asthma death occurs in low and lower-middle 
income countries. 
· Asthma is under-diagnosed and under-treated.
in 2005 in the world.
1
EVOLUTION OF ASTHMA CONCEPT
Treatment of asthma progressed aligned with evolution of 
concept of asthma.
2 In the middle part of 20th century asthma 
was called as a disease or symptom complex which showed 
paroxysmal dyspnea with reversible bronchoconstriction. Spasm 
of bronchial smooth muscle was thought to be major mecha-
nism of airway narrowing.
3 Accordingly, bronchodilators in-
cluding epinephrine, isoproterenol and theophyllines were 
major agents to treat asthma attacks. In 1960s asthma was de-
fined as disease of airway hyperresponsiveness.
4,5 Around 
1980s, inflammation of the airway was found to be related with 
airway hyperresponsiveness and asthma symptoms. Eosino-
phils are most outstanding cells in the airway of asthma pa-
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tients. Eosinophils are found to cause or contribute to histologi-
cal and functional changes in the airway of asthma patients in-
cluding desquamation of bronchial epithelium and airway hy-
perresponsiveness.
6-8 Anti-inflammatory agents including corti-
costeroids, anti-allergic agents, theophyllines, are used to sup-
press eosinophilia in the airway and has been proved to be ef-
fective.
9,10 Following studies on pathophysiology of asthma have 
shown that many cells and cytokines have roles in the inflam-
mation of the airway of asthma patients in complicated man-
ner.
11 Structural change of the airway due to airway inflamma-
tion (airway remodeling) has been shown to contribute to per-
sistent airway narrowing and airway hyperresponsiveness (Fig. 
1). 
12
AIRWAY REMODELING AND SMAD PROTEINS
The basic pathological features of bronchial asthma can be 
explained on the basis of chronic airway inflammation, involv-
ing inflammatory cells such as T cells (particularly type 2 help-
er T, Th2 cells) and mast cells, and airway remodeling. Airway 
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remodeling causes persistent airway narrowing and airway hy-
perresponsiveness.
12 In fact back to 1966 Makino found that 
asthma patients with low FEV1/Predicted VC had increased air-
way responsiveness.
13
Recent attention has focused on the role of transforming growth 
factor (TGF)-beta, a fibrogenic cytokine, in airway remodeling. 
Currently available evidence suggests that airway remodeling is 
caused by an imbalance in regulatory mechanisms mediated 
by Smads, a family of signal-transducing molecules of TGF-be-
ta. Smad7 is an intracellular antagonist of TGF-beta signaling, 
which could determine the intensity or duration of the TGF-be-
ta signal. Sagara, Nakao and others found that the expression of 
Smad7 in bronchial epithelial cells is inversely correlated to base-
ment membrane thickness and airway hyperresponsiveness in 
patients with asthma, while the expression of phosphorylated 
activated Smad2 (p-Smad2) is positively correlated with them.
14,15 
Intracellular level of Smad protein is controlled by cytokines. 
Fueki, Sagara and other found the effects of the Th2 cytokines 
interleukin (IL)-5 and granulocyte-macrophage colony-stimu-
lating factor (GM-CSF), and the regulatory cytokine IL-10 on 
the expression of inhibitory Smad7 protein in bronchial epithe-
lial cells IL-10 inhibited the expression of TGF-beta-inducible 
early gene, which is known to down-regulate Smad7 expres-
sion.
16 McMillan and others found budesonide treatment regu-
lated active TGF-beta signaling with a reduction in the expres-
sion of Smad2 and the concomitant up-regulation of Smad7 in 
lung tissue sections of experimental asthma of mice.
17
These observations suggest that airway remodeling can be 
controlled by drugs and cytokines which suppress airway in-
flammation with modulation of signaling of TGF-beta (Fig. 2-1, 
2-2).
ASTHMA MANAGEMENT GUIDELINES 
In 1992 International Consensus Report for the Diagnosis and 
Management of asthma was released.
18 Global Initiative for 
Asthma (GINA) started in 1993 and was published in 1995. GINA 
was developed on the concept of airway inflammation of the 
airway.
19
In Japan of 1993, Asthma Prevention and Management Guide-
lines (JGL) was first developed by Japanese Society of Allergolo-
gy.
20-22 Like GINA JGL has been produced with the concept that 
asthma is an inflammatory disease of the airway, and its treat-
ment is aimed at prevention and control of airway inflamma-
tion. This concept is new and different from the previous under-
standing of asthma. Since then JGL has been revised in 1997, 
2002, 2006, and 2009, and accepted as the standard of asthma 
management in Japan.
23
EVALUATION OF ASTHMA-MANAGEMENT GUIDELINES 
Effectiveness of asthma management guidelines can be eval-
uated by the change of death from asthma comparing before 
and after implementation of JGL, and trend of medical expens-
es for the treatment of asthma. The total number of death from 
asthma for each year was obtained by the report of Ministry of 
Fig. 1. Evolution of Asthma Concept from Makino S.
2 
ATS, American Thoracic Society; ICR, International Consensus Report; JGL, Japanese Asthma Prevention and Management Guidelines; GINA, Global Initiative for 
Asthma. 
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Health, Welfare and Labor, Japan.
24
Death from asthma seems to have started to decrease contin-
uously around 1997 to 2008. The total number of death from 
asthma from 1993 to 1998 was approximately 5900, and it was 
2300 in 2008. JGL has been widely known in both specialists 
and non-specialists and widely accepted. Increased use of anti-
inflammatory agents including inhaled corticosteroids is thought 
to be one of causes of this decrease (Fig. 3). 
20,23
GINA has been accepted as a template of national asthma 
management guidelines in many of countries in Asia Pacific. 
Implementation of asthma management guidelines with con-
cept that asthma is an inflammatory disease of airway would be 
effective to decrease of death from asthma in both developed 
and developing countries.
Another important issue on asthma control is its expense. 
While in Japan the death from asthma has decreased drastically 
for the past one decade, direct medical expense for asthma treat-
ment has not increased.
24 This finding suggests that proper im-
plementation of asthma management guidelines is not expen-
sive and would contribute to the social productivity by decreas-
ing work loss and absence for school.
REMAINING PROBLEM: HIGH RATE OF DEATH FROM 
ASTHMA IN ELDERLY GENERATION 
Death from asthma has decreased in children to younger adult 
populations, while it is still high in elderly population especially 
65 years and over. This can be partly due to increase of elderly 
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Fig. 2-1. Smad7 seems to suppress thickening of bronchial basement membrane in asthma.
15 MB: Basement membrane of the epithelium.
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Fig. 2-2. p-Smad2 expression level in bronchial epithelial cells was elevated in asthma. Basement membrane thickness was correlated with Smad2 expression level 
in the airway of mild to severe asthmatics.
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population at larger. In fact population 65 years and over is ap-
proximately 23% of total Japanese population in 2009. Appar-
ently, control of death from asthma in elderly population is an-
other target of Japanese Guidelines.
25
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